Published online before print March 26, 2009

This Article Full Text Full Text (PDF) All Versions of this Article: jmoldx.2009.080142v1 11/3/238    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pino, M. S. Articles by Chung, D. C. Search for Related Content PubMed PubMed Citation Articles by Pino, M. S. Articles by Chung, D. C.

Journal of Molecular Diagnostics 2009, Vol. 11, No. 3
Copyright © 2009 American Society for Investigative Pathology & Association for Molecular Pathology
DOI: 10.2353/jmoldx.2009.080142

Deficient DNA Mismatch Repair Is Common in Lynch Syndrome-Associated Colorectal Adenomas

Maria Simona Pino^*, Mari Mino-Kenudson, Bernadette Mandes Wildemore, Aniruddha Ganguly, Julie Batten, Isabella Sperduti, Anthony John Iafrate and Daniel C. Chung^*¶

From the Gastrointestinal Unit, * the Department of Pathology, and the Cancer Center, ^¶ Massachusetts General Hospital, Boston, Massachusetts; and the Medical Oncology Department, and Department of Biostatistics, Regina Elena National Cancer Institute, Rome, Italy

Lynch syndrome is caused by germline mutations in DNA mismatch repair (MMR) genes. Both microsatellite instability (MSI) testing and immunohistochemical analyses (IHC) of colon cancers are valuable diagnostic strategies for Lynch syndrome. We sought to determine whether these markers of MMR deficiency were also detectable in pre-cancerous colorectal adenomas. Fifteen subjects with a germline MMR gene mutation who had 44 adenomas removed during surveillance colonoscopy were identified. MSI testing and IHC for MLH1, MSH2, and MSH6 were performed. MSI was detected in 23 adenomas. There was a significant association between MSI and high-grade dysplasia (P = 0.006) and distal location (P = 0.0008). Loss of MMR protein by IHC was detected in 31 adenomas. A significant association was observed between loss of staining by IHC and high-grade dysplasia (P = 0.04). Among the 40 adenomas in which both MSI tests and IHC were performed, the presence of a germline mutation correlated with an abnormal MSI result in 58% of cases, an abnormal IHC result in 70% of cases, and either an abnormal MSI or IHC result in 73% of cases. The combination of MSI and IHC testing in colorectal adenomas is a sensitive screen for the detection of Lynch syndrome and may be particularly useful when Lynch syndrome is suspected and adenomatous polyps are the only tissues available for analysis.